Imaging the neurochemistry of nicotine actions: Studies with positron emission tomography

Nicotine and Tobacco Research

Volumn 1, Issue SUPPL. 2, 1999, Pages

  Volkow, N D ^a,b   Fowler, J S ^a   Ding, Y S ^a   Wang, G J ^a   Gatley, S J ^a  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b Medical Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); NICOTINE; NICOTINIC RECEPTOR;

BLOOD; BRAIN; BRAIN CIRCULATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG EFFECT; HUMAN; METABOLISM; REVIEW; SCINTISCANNING;

BRAIN; CEREBROVASCULAR CIRCULATION; HUMAN; MONOAMINE OXIDASE; NICOTINE; RECEPTORS, NICOTINIC; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033302674     PISSN: 14622203     EISSN: None     Source Type: Journal    
DOI: 10.1080/14622299050011941     Document Type: Article

References (19)

1. 11C-nicotine vapor in the human airway as visualized by positron emission tomography. Clinical Pharmacology Therapeutics 57:309-317.
2. Ding Y-S, Gatley SJ, Fowler JS, Volkow ND, Aggarwal N, Logan J, Dewey SL, Liang, F, Carroll FI, Kuhar MJ. 1996. Mapping nicotinic acetylcholine receptors with PET. Synapse 24:403-407.
3. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf AP, Warner D, Zezulkova I, Cilento R. 1996a. Inhibition of monoamine oxidase B in the brains of smokers. Nature 379:733-736.
4. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, Shea C, Alexoff D, MacGregor RR, Schlyer DJ, Zezulkova I, Wolf AP. 1996b. Brain monoamine oxidase A inhibition in cigarette smokers. Proceedings of the National Academy of Science USA 93:14065-14069.
5. Fowler JS, Volkow ND, Logan J, Pappas N, King P, Macgregor RR, Shea C, Garza V, Gatley SJ. 1998. An acute dose of nicotine does not inhibit MAO B in the baboon brain in vivo. Life Sciences 63:19-23.
6. Fujishiro K, Kodaira K, Wada T, Tsukiyama E. 1995. Effects of smoking a tobacco cigarette on carotid and cerebral blood flow. In: Domino EF, ed. Brain Imaging of Nicotine and Tobacco Smoking. Ann Harbor, MI: NPP Books, pp. 123-135.
7. Classman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, Johnson J. 1990. Smoking, smoking cessation and major depression. Journal of the American Medical Association 264:1546-1549.
8. Henningfield JE, Clayton R, Pollin W. 1990. Involvement of tobacco in alcoholism and illicit drug use. British Journal of Addiction 85:279-292.
9. 11C]A-84543: an enantioselective ligand for in vivo studies of neuronal nicotinic acetylcholine receptors. Life Sciences 63:13-18.
10. Mata M, Fink DJ, Gainer H. 1980. Activity-dependent energy metabolism in rat posterior pituitary primarily reflects sodium pump activity. Journal of Neurochemistry 34:213-215.
11. Molina PE, Ding Y-S, Carroll IF, Liang F, Volkow ND, Pappas N, Kuhar M, Abumrad NN, Gatley SJ, Fowler JS. 1997. Fluoronorchloroepibatidine: preclinical assessment of acute toxicity. Nuclear Medicine and Biology 24:743-747.
12. Nagata K, Shinohara T, Kanno I, Hatazawa J, Domino EF. 1995. Effects of tobacco cigarette smoking on cerebral blood flow in normal adults. In: Domino EF, ed. Imaging of Nicotine and Tobacco Smoking. Ann Harbor, MI: NPP Books, pp. 95-108.
13. 11C]nicotine in the human brain: difficulties in visualizing specific receptor binding in vivo. Psychopharmacology 115:31-36.
14. Oldendorf WH. 1992. Some relationships between addiction and drug delivery to the brain. In: Frankenheim J, Brown RM, eds. Bioavailability of Drugs to the Brain and the Blood Brain Barrier: NIDA Research Monograph 120. Washington DC: Government Printing Office, pp. 13-25.
15. Parks RW, Becker RE, Rippey RF, Gilbert DG, Matthews JR, Kabatay E, Young CS, Vohs C, Danz V, Keim P, Collins GT, Zigler SS, Urycki PG. 1996. Increased regional cerebral glucose metabolism and semantic memory performance in Alzheimer's disease: a pilot double blind transdermal nicotine positron emission tomography study. Neuropsychology Reviews 6:61-79.
16. Rourke SB, Dupont RM, Grant I, Lehr PP, Lamoureux G, Halpern S, Yeung DW. 1997. Reduction in cortical IMP-SPECT tracer uptake with recent cigarette consumption in a young group of healthy males. San Diego HIV Neurobehavioral Research Center. European Journal of Nuclear Medicine 24:422-427.
17. Stapleton JM, Henningfield JE, Wong DF, Phillips RL, Grayson RF, Dannals RF, London ED. 1993. Nicotine reduces cerebral glucose utilization in humans. NIDA Research Monograph 132, p. 106.
18. Stein EA, Pankiewicz J, Harsch HH, Cho JK, Fuller SA. Hoffmann RG, Hawkins M, Rao S, Bandettini PA, Bloom AS. 1998. Nicotine induced limbic cortical activation in the human brain: a functional MRI study. American Journal of Psychiatry 155:1009-1015.
19. Villemagne VL, Horti A, Scheffel U, Ravert HT, Finley P, Clough DJ, London ED, Wagner HN Jr, Dannals RF. 1997. Imaging nicotinic acetylcholine receptors with fluorine-18-FPH, an epibatidine analog. Journal of Nuclear Medicine 38:1737-1741.